Viewing StudyNCT02225002



Ignite Creation Date: 2024-05-06 @ 3:11 AM
Last Modification Date: 2024-10-26 @ 11:29 AM
Study NCT ID: NCT02225002
Status: COMPLETED
Last Update Posted: 2018-08-28
First Post: 2014-08-22

Brief Title: Phase 1 Open-Label Dose-Escalation Study of CP-870893 in Patients With Solid Tumors
Sponsor: Abramson Cancer Center at Penn Medicine
Organization: Abramson Cancer Center at Penn Medicine

Conditions & Keywords Data

Conditions:
Name
Advanced Solid Tumors
Keywords:
Name View
relapsed View
refractory to standard therapy View
no effective therapy exists View